About Us
Our Mission
Leadership
Board of Directors
Scientific Advisory Board
Contact Us
Our Technology
Therapeutic Platforms
SQZ Pipeline
SQZ APC PLATFORM
SQZ AAC PLATFORM
SQZ TAC PLATFORM
For Patients
Investors and Media
Work At SQZ
SQZ play: Roche doubles down on a $1.37B-plus deal for a new approach to immuno-oncology out of Bob Langer’s lab